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The July 7 automobile accident that
claimed the lives of Anne McLaren
and her former husband, Donald
Michie, marked the end of a 5 decades
long era that gave birth to the fields of
mammalian reproductive genetics and
stem cell biology. AnneMcLarenmade
pioneering contributions to two major
pillars of both fields: mammalian em-
bryonic development and the ethical
implications of embryo research.
On April 26, 1927, Anne McLaren
was born into a liberal British industri-
alist family, daughter of Henry McLa-
ren, second Baron Aberconway, and
Christabel McNaughton. Anne spent
her childhood between the family’s
homes in London andBondnant, North
Wales, andwas educated at Longstow
Hall, Cambridgeshire. She attended
Oxford University, Lady Margaret
Hall, attaining a first in zoology, then
continued at Oxford for her doctor of
philosophy, awarded in 1952. She
then took up her first post as research
associate with Peter Medawar at Uni-
versity College London, be-
ginning a collaboration with
Donald (a recruit to genetics
from his codebreaking work
at Bletchley Park), whom
she had married earlier that
year. Together, they studied
the genetic and environmen-
tal basis of skeletal variation
in mice, a subject to which
she would return in her sub-
sequent studies of mamma-
lian chimeras. Anne and
Donald continued their stud-
ies after moving to the Royal
Veterinary College, London,
in 1955, where they met
John Biggers. Following the
demonstration by Wesley
Whitten that early mouse
embryos could be cultivated
in a simple solution of salts
and sugars (Whitten, 1957),
Anne and John made the
pioneering discovery that
cultured mouse embryos
could be transplanted to the
uteri of foster mothers, with
successful full-term devel-
opment as normal mice (McLaren
and Biggers, 1958). Their publication
opened the field of experimental mam-
malian embryology, with its ultimate
culmination in chimeras, embryonic
stem cells, gene targeting, and, in the
clinical arena, in vitro fertilization and
regenerative medicine.
In 1959, Anne moved to Edinburgh
with Donald and their family, where
she joined C.H. Waddington’s ARC
Animal Genetics Unit. Anne collabo-
rated further with Donald, despite their
divorce, but greatly expanded her own
interests in mouse reproductive biol-
ogy, establishing much of the now-
standard base of knowledge for this
species. Her dynamic approach ex-
tended beyond the specific findings
of embryology. In 1960, the Polish em-
bryologist A.K. Tarkowski discovered
that two mouse embryos could be ag-
gregated to generate a single chimeric
conceptus and result in a single mo-
saic mouse with four parents; Anne
led the way to teaching the method
to other scientists, obviating the diffi-
culties of travel to and from the Soviet
bloc and circumventing a developing
monopoly on the chimera approach
by a leading U.S. researcher. In addi-
tion to her own numerous research
contributions using the chimera ap-
proach, in 1972 Anne published an in-
fluential paper on the interpretation of
chimera coat color patterns, correct-
ing popular misconceptions on the
number of founder cells in stem cell
populations for the developing organ
rudiments (McLaren, 1972). Thus, it
became evident that Anne’s interests
included both the factual substance
of science and its political environ-
ment, and her influence expanded far
beyond her scientific publications.
In 1974, Anne moved to University
College London as director of a unit on
mammalian development, which the
Medical Research Council convened
around her. There she continued her
distinguished research career, further
developing an interest in primordial
germ cells that had seem-
ingly arisen during her stud-
ies of the inheritance pat-
terns of mouse chimeras
(McLaren et al., 1972; McLa-
ren, 1975). In 1976, Anne
summarized then-current
concepts in early mamma-
lian development in her sem-
inal Mammalian Chimaeras,
a diminutive monograph
that, like its author, spoke
volumes in a few carefully
chosen words (McLaren,
1976). In her 18 years as
unit director, Anne was to in-
fluence the lives of countless
junior researchers, develop-
ing their careers as students,
fellows, and group leaders.
Her contributions to under-
standing the mechanisms of
mammalian sex determina-
tion, using a combination of
genetic and embryonic ap-
proaches, laid the foundation
for the definitive insights later
gained by her colleagues.
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thorship only in those publications to
which she personally contributed data.
When in 1992 retirement was pre-
scribed for her at age 65 by the Medi-
cal Research Council, Anne relocated
to the University of Cambridge, where
she continued in active research. She
joined John Gurdon’s Wellcome Trust/
Cancer Research UK Institute for Can-
cer and Developmental Biology as a
principal research associate, where
her interests focused increasingly on
primordial germ-cell-derived pluripo-
tent stem cells. As before, Anne con-
tinued to publish high-impact journal
articles in which she herself played
a key experimental role. ‘‘It’s much
easier to teach how to dig,’’ she said,
‘‘if you’re already standing in the
trench.’’ Her most recent digging re-
vealed key insights into the timing
and gender specificity of imprinting in
germ cells (Durcova-Hills et al.,
2006a, 2006b; Ko andMcLaren, 2006).
During this recent period, Anne also
progressively expanded her activities
in support of public understanding of
stem cell research ethics and social
policy. This reflected Anne’s profound
awareness that science is part of the
fabric of society. She knew that sci-
ence could not progress despite pub-
lic opinion, and that scientists must
engage and respond to the cultural
sensitivities that their discoveries pro-
voked. Working as she did with novel
advances in reproductive biology,
she found the moral status of the hu-
man embryo, in particular, a constant
ethical companion. With her custom-
ary inventiveness and flair, she devel-
oped this dimension of her research,
becoming a familiar and respected
figure in the expanding public arena
of ethics of science. She recognized
that the application of ethics to science
at times requires legislative backing if it
is to have the authority both to govern
the science and to ensure public trust.
She had been an influential member
of the Warnock Committee on Human
Fertilisation and Embryology that was
convened in the heated climate that
accompanied thebirthofLouiseBrown
in 1978. There, she was a forceful ad-
vocate of the ‘‘14 day rule,’’ arguing
persuasively that research on pregas-
trulation stage human embryos was138 Cell Stem Cell 1, August 2007 ª2007justified on the basis that true individu-
ation could not have occurred until
twinning was no longer possible. The
ensuing Warnock Report of 1984 de-
fined the legal framework that still
informs the governance of human em-
bryo research in theUKandelsewhere.
The UK debate on human embryo re-
search ethics continued for a further 6
years after 1984, with sustained shep-
herding by Anne, until the Human Fer-
tilisation and Embryology (HFE) Act
was passed in 1990.
Anne also appreciated that it was
essential for researchers to become
involved in the implementation of the
policies that govern them. She be-
came a founding member of the
Human Fertilisation and Embryology
Authority (HFEA) (created in 1991 as
part of the 1990 HFE Act) and contin-
ued in this role until 2001. As chair of
the Authority’s working group on
new developments in reproductive
technology, she was involved in the
joint HFEA/Human Genetics Advisory
Committee (HGAC) working group that
launched the national debate on clon-
ing issues in reproduction, science,
and medicine in 1998. It was as a re-
sult of this debate that the HFEA Act
was amended by Parliament to allow
the use of human embryos in stem
cell research leading to the treatment
of serious diseases. However, where
she felt it was not in the public inter-
est, she did not hesitate to resist par-
ticular developments, articulating, for
example, the HFEA’s 1999 opposition
to the use of spermatid injection for
IVF. In parallel to her work for the
HFEA, Anne served as a member of
the Nuffield Council on Bioethics
from its foundation in 1991. In this in-
dependent role, she was once again
closely involved in the debates on
therapeutic cloning and with the pro-
duction of the Council’s paper titled
‘‘Stem Cell Therapy: The Ethical Is-
sues.’’ Interestingly, this concluded
that as long as there were sufficient
spare embryos donated for use in re-
search from IVF treatments, there
were no compelling reasons to allow
the creation of additional embryos.
These examples provide further evi-
dence that she viewed the needs of
scientific advance in balance with a
respect for social values.Elsevier Inc.Anne’s approach to the ethical and
social debate was distinctly interna-
tional. She was amember of the Group
of Advisors to the European Commis-
sion on the Ethical Implications of
Biotechnology from 1994 to 1997 and
thereafter of its successor, the Euro-
pean Group on Ethics in Science and
New Technologies (EGE). She made
influential contributions to its ‘‘Opin-
ions’’ on topics of concern to the Com-
mission and its formal incorporation
into EU directives and procedures,
serving as the lead rapporteur for the
Opinions ‘‘Ethical Aspects of Cloning
Techniques’’ (1997), ‘‘Ethical Aspects
of Research Involving the Use of the
Human Embryo in the Context of the
Fifth Framework Programme’’ (1998),
and ‘‘Ethical Aspects of Human Stem
Cell Research and Use’’ (2000).
Ultimately, there were few consulta-
tions or inquiries in the fields of human
reproduction, genetics, cloning, or
stem cells with which she was not con-
nected. Anne inspired many people,
particularly the young, through her
efforts to make the science relating to
embryos and stem cells widely acces-
sible. She traveled worldwide in re-
sponse to the unceasing demand for
her insight and clarity. On television
and with student audiences, she was
a ‘‘natural’’: lucid and convincing. Dur-
ing the past few years, Anne served
as a trustee of the Frozen Ark Project,
which she had cofounded, with the
aim of preserving DNA and cells of
the world’s endangered species; she
was a long-term member of the Pug-
wash Conferences on Science and
World Affairs, which are devoted to re-
ducing the danger of armed conflicts
and raising the awareness of ethical is-
sues arising from scientific advances.
She belonged everywhere, and to
many more people than to just her stu-
dents, her fellows, her colleagues, and
her own loving family: she was a truly
public scientist. We are all truly fortu-
nate that the life of this key pioneer of
our field overlapped sufficiently with
our own that we could personally ap-
preciate and acknowledge her many
contributions.
Such a distinguished career as
Anne McLaren’s would understand-
ably attract recognition from many
sources. She became a Fellow of the
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eign secretary from 1991 to 1996 and
Vice President from 1992 to 1996, be-
ing the first female officer in its 331
year history. She was a fellow of
King’s College, Cambridge 1992–
2007 (Honorary Fellow from 1996 until
her death); she was also Fellow Com-
moner at Christ’s College, Cam-
bridge. She was made a Dame of
the British Empire (DBE) in 1993, but
avoided use of the title, preferring
Dr. instead. She received the Japan
Prize jointly with A.K. Tarkowski in
2002 and the March of Dimes Medal
jointly with Janet Rossant in 2007.
She was the author of hundreds of
publications and the recipient of nu-
merous other honors and awards.
Anne McLaren is survived by her
daughters, Susan Michie and
Caroline Michie, her son, Jonathan
Michie, and her stepson, Chris
Michie. Contributions to the AnneMcLaren Memorial Fund will support
women scientists.
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